Structure-based design of pan-coronavirus inhibitors targeting host cathepsin L and calpain-1

Xiong Xie1,2, Qiaoshuai Lan3, Jinyi Zhao2,4

  • 1Drug Discovery and Design Center, State Key Laboratory of Drug Research, CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.

Insights

Two novel compounds, 14a and 14b, effectively inhibit host proteases Cathepsin L and calpain-1, demonstrating broad-spectrum antiviral activity against SARS-CoV-2 variants and HCoV-OC43, with promising anti-inflammatory effects.

Area of Science:

  • Virology
  • Drug Discovery
  • Immunology

Background:

  • Emerging coronaviruses pose a global health threat, necessitating novel therapeutic strategies beyond existing vaccines and antivirals.
  • Host-targeting antivirals offer a promising approach to combat viral resistance and future outbreaks.
  • Cathepsin L (CTSL) and calpain-1 (CAPN1) are critical host proteases involved in coronavirus entry and immune responses.

Purpose of the Study:

  • To identify and characterize novel dual inhibitors targeting CTSL and CAPN1 for broad-spectrum coronavirus treatment.
  • To evaluate the in vitro and in vivo antiviral efficacy and safety of these inhibitors against SARS-CoV-2 and other coronaviruses.
  • To assess the anti-inflammatory properties of the identified compounds.

Main Methods:

  • Identification of peptidomimetic α-ketoamide compounds (14a and 14b) as dual CTSL and CAPN1 inhibitors.
  • X-ray crystallography to elucidate the binding mechanism of compounds with CTSL and CAPN1.
  • In vitro antiviral assays against SARS-CoV-2 and its variants, and HCoV-OC43.
  • In vivo studies in mouse models to assess pharmacokinetic properties, safety, antiviral efficacy, and anti-inflammatory effects.

Main Results:

  • Compounds 14a and 14b potently inhibited CTSL and CAPN1, with X-ray structures confirming covalent binding.
  • Both compounds demonstrated broad-spectrum in vitro antiviral activity, including low nanomolar potency against SARS-CoV-2 and its variants (VOCs).
  • In vivo studies showed favorable oral pharmacokinetics, good safety profiles, potent antiviral activity against SARS-CoV-2 XBB 1.16 and HCoV-OC43, and significant anti-inflammatory effects.

Conclusions:

  • Compounds 14a and 14b are potent dual inhibitors of CTSL and CAPN1 with broad-spectrum antiviral and anti-inflammatory properties.
  • These compounds represent promising drug candidates for developing pan-coronavirus inhibitors.
  • The findings offer novel insights into host-targeting strategies for managing current and future coronavirus threats.

Related Concept Videos

Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside...
8.7K
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
216
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
127
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
73
Anthelminthic Agents01:15

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
115